Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

HERNING DYREHOSPITAL ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   2.5% 1.9% 1.2% 1.3% 1.3% 1.7% 13.2% 12.9%   Credit score (0-100)   64 71 81 79 78 72 17 18   Credit rating   BBB A A A A A BB BB   Credit limit (kDKK)   0.0 0.4 57.1 43.5 24.9 2.9 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,925 3,420 3,430 3,621 3,407 2,786 0.0 0.0   EBITDA   358 393 889 786 686 492 0.0 0.0   EBIT   236 298 790 681 569 339 0.0 0.0   Pre-tax profit (PTP)   168.3 242.4 747.9 617.1 540.8 315.3 0.0 0.0   Net earnings   131.0 197.9 592.0 490.2 430.3 254.0 0.0 0.0   Pre-tax profit without non-rec. items   168 242 748 617 541 315 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   2,947 2,852 2,878 2,981 3,154 3,223 0.0 0.0   Shareholders equity total   818 1,016 1,508 1,498 1,428 1,432 1,182 1,182   Interest-bearing liabilities   1,496 1,490 1,355 1,322 1,250 1,231 0.0 0.0   Balance sheet total (assets)   3,497 3,452 4,108 3,941 3,806 3,658 1,182 1,182   Net Debt   1,479 1,347 1,005 741 1,016 1,179 -1,182 -1,182     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,925 3,420 3,430 3,621 3,407 2,786 0.0 0.0   Gross profit growth   -4.4% 16.9% 0.3% 5.5% -5.9% -18.2% -100.0% 0.0%   Employees   6 6 6 8 6 5 0 0   Employee growth %   0.0% 0.0% 0.0% 33.3% -25.0% -16.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,497 3,452 4,108 3,941 3,806 3,658 1,182 1,182   Balance sheet change%   -3.8% -1.3% 19.0% -4.1% -3.4% -3.9% -67.7% 0.0%   Added value   358.3 393.2 889.1 785.9 674.4 491.8 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -217 -191 -73 -3 56 -84 -3,223 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   8.1% 8.7% 23.0% 18.8% 16.7% 12.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   6.7% 8.8% 21.0% 17.0% 14.7% 9.1% 0.0% 0.0%   ROI %   9.3% 11.7% 26.8% 21.4% 18.1% 10.9% 0.0% 0.0%   ROE %   17.4% 21.6% 46.9% 32.6% 29.4% 17.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   23.4% 29.4% 36.7% 38.0% 37.5% 39.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   412.7% 342.7% 113.0% 94.3% 148.0% 239.7% 0.0% 0.0%   Gearing %   182.9% 146.7% 89.9% 88.2% 87.5% 85.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.4% 4.3% 3.2% 5.0% 2.3% 2.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.1 0.2 0.8 0.7 0.4 0.1 0.0 0.0   Current Ratio   0.4 0.7 1.2 1.2 0.8 0.6 0.0 0.0   Cash and cash equivalent   16.7 142.6 350.2 580.5 234.3 51.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -885.6 -244.0 236.0 145.7 -118.9 -241.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   60 66 148 98 112 98 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   60 66 148 98 114 98 0 0   EBIT / employee   39 50 132 85 95 68 0 0   Net earnings / employee   22 33 99 61 72 51 0 0